pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    AMB-051
    Tenosynovial Giant Cell Tumor AmMax Bio Inc
  • Preclinical
    AMB-304
    Colorectal Cancer AimedBio Inc
  • Preclinical
    AMI-463
    Childhood Rhabdomyosarcoma Amira Therapeutics SL
  • Preclinical
← prev
page 9 of 62
next →
Pain89
Neurology1
AMP-105
Head And Neck Squamous Cell Carcinoma (HNSC)
$AMPH Amphastar Pharmaceuticals, Inc.
  • Preclinical
    AMP-109
    Colorectal Cancer$AMPH Amphastar Pharmaceuticals, Inc.
  • Phase 1
    AMT-754
    Bladder Cancer ADCendo ApS
  • Preclinical
    AMX-883
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Amphista Therapeutics Ltd
  • Phase 1
    AN-4005
    Diffuse Large B-Cell Lymphoma Adlai Nortye Biopharma Co Ltd
  • Phase 1
    AN-9025
    Bile Duct Cancer (Cholangiocarcinoma) Adlai Nortye Biopharma Co Ltd
  • Phase 1
    AND-019
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Kind Pharmaceuticals
  • Phase 2
    ANS-01
    Non-Small Cell Lung Cancer Avistone Biotechnology Co Ltd
  • Phase 1
    ANS-03
    Solid Tumor Avistone Biotechnology Co Ltd
  • Preclinical
    ANT-308 Fc3
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Cambium Oncology LLC
  • Preclinical
    ANV-221
    Pancreatic Cancer Anviron Corp
  • Phase 2
    ANV-419
    Metastatic Melanoma Anaveon AG
  • Phase 2
    ANV-600
    Melanoma Anaveon AG
  • Preclinical
    AP-001
    Metavert
    Pancreatic Cancer Avenzoar Pharmaceuticals Inc
  • Phase 2
    AP-030
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Apollo Therapeutics Ltd
  • Phase 2
    APG-157
    Squamous Cell Carcinoma Aveta Biomics Inc
  • Preclinical
    APG-3526
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
  • Phase 1
    APG-5918
    Castration-Resistant Prostate Cancer (CRPC)$AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
  • Preclinical
    APL-1501
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… Asieris Pharmaceuticals (USA) Inc
  • Phase 2
    APL-2302
    Breast Cancer Asieris Pharmaceuticals (USA) Inc
  • Phase 1
    APN-401
    Head And Neck Squamous Cell Carcinoma (HNSC) InvIOs GmbH
  • Phase 1
    APR-1051
    Breast Cancer$APRE Aprea Therapeutics, Inc.
  • Phase 2
    APS-03118
    Medullary Thyroid Cancer Applied Pharmaceutical Science Inc
  • Preclinical
    APT-002
    Glioblastoma Multiforme (GBM) Aptah Bio Inc
  • Phase 2
    APTA-16
    Myelodysplastic Syndrome (Preleukemia) AptaBio Therapeutics Inc
  • Preclinical
    AQ-004
    Lung Cancer Aquilon Pharmaceuticals SA
  • Preclinical
    AR-170
    Solid Tumor Y-Biologics Inc